Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes is a research paper published in Endocrinology (2020). On theSindex it has a DataRank of 0. It has been cited 268 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DK107444
National Institutes of Health
Grant: DK074970
U.S. Department of Veterans Affairs
Grant: BX003725
U.S. Department of Veterans Affairs
Grant: BX002316
National Institute on Aging
Grant: U54AG062333
BLRD VA
Grant: I01 BX002316
NIDDK NIH HHS
Grant: R01 DK074970
NIDDK NIH HHS
Grant: R01 DK107444
BLRD VA
Grant: I01 BX003725
National Institutes of Health
Grant: 3U54AG062333-04S1
Sex and Age Differences in Immunity to Influenza (SADII)
National Institutes of Health
Grant: 5R01DK107444-02
Repurposing estrogens to improve pancreatic islet transplantation
National Institutes of Health
Grant: 5R01DK074970-02
Role of estrogen receptors in pancreatic beta-cell survival and insulin secretion
Office of Research on Women's Health
FWCI
36.14
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals